Clinical trial

Nonmyeloablative Allogeneic Transplant

NCT01272817

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-10-01

PhaseNA

Study timeline

Study start (unknown)2001-10-01Date precision: month

Registry last updated2022-11-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Aplastic Anemiaverified · MONDO: aplastic anemia

Paroxysmal Nocturnal Hemoglobinuriaverified · MONDO: paroxysmal nocturnal hemoglobinuria

Acute Myelogenous Leukemiaverified · MONDO: acute myeloid leukemia

Acute Lymphocytic Leukemiaverified · MONDO: acute lymphoblastic leukemia

Myelodysplastic Syndromeverified · MONDO: myelodysplastic syndrome

Chronic Myelogenous Leukemiaverified · MONDO: chronic myeloid leukemia

Chronic Lymphocytic Leukemiaverified · MONDO: B-cell chronic lymphocytic leukemia

Hodgkin's Lymphomaverified · MONDO: Hodgkins lymphoma

Non-Hodgkin's Lymphomaverified · MONDO: non-Hodgkin lymphoma

Mantle Cell Lymphomaverified · MONDO: mantle cell lymphoma

Multiple Myelomaunresolved

Waldenstrom Macroglobulinemiaverified · MONDO: Waldenstrom macroglobulinemia

Breast Cancerverified · MONDO: breast cancer

Renal Cell Carcinomaverified · MONDO: renal cell carcinoma

Melanomaverified · MONDO: melanoma

Sarcomaverified · MONDO: sarcoma

Ovarian Cancerverified · MONDO: ovarian cancer

Thymomaverified · MONDO: thymoma

Interventions

Nonmyeloablative Allogeneic TransplantPROCEDURE

Nonmyeloablative Allogeneic TransplantPROCEDURE

Sponsors & collaborators

Scripps Healthlead sponsor

Mapped research locations

La JollaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01272817 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.